Estrogen Inhibits Glucocorticoid Action via Protein Phosphatase 5 (PP5)-mediated Glucocorticoid Receptor Dephosphorylation*
暂无分享,去创建一个
[1] V. Jordan,et al. Selective estrogen modulators as an anticancer tool: mechanisms of efficiency and resistance. , 2008, Advances in experimental medicine and biology.
[2] D. Edwards,et al. The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression , 2008, Steroids.
[3] S. Weiss,et al. Airway responsiveness in mild to moderate childhood asthma: sex influences on the natural history. , 2008, American journal of respiratory and critical care medicine.
[4] C. Cavasotto,et al. Glucocorticoid receptor phosphorylation differentially affects target gene expression. , 2008, Molecular endocrinology.
[5] K. Kang,et al. Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells. , 2008, Chemico-biological interactions.
[6] R. Samant,et al. Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer. , 2008, Biochimica et biophysica acta.
[7] H. Chao,et al. The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene. , 2008, Taiwanese journal of obstetrics & gynecology.
[8] K. Blackwell,et al. Aromatase inhibitors for breast cancer: proven efficacy across the spectrum of disease. , 2008, Clinical breast cancer.
[9] J. Nabholtz. Long-term safety of aromatase inhibitors in the treatment of breast cancer , 2008, Therapeutics and clinical risk management.
[10] R. Weinshilboum. Pharmacogenomics of endocrine therapy in breast cancer. , 2008, Advances in experimental medicine and biology.
[11] T. Hinds,et al. Protein phosphatase 5. , 2008, The international journal of biochemistry & cell biology.
[12] Bruce D Keith,et al. Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy , 2008, BMC Cancer.
[13] E. Kawasaki,et al. Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. , 2007, Molecular endocrinology.
[14] M. Garabedian,et al. Modulation of glucocorticoid receptor phosphorylation and transcriptional activity by a C-terminal-associated protein phosphatase. , 2007, Molecular endocrinology.
[15] I. Adcock,et al. Update on glucocorticoid action and resistance. , 2006, The Journal of allergy and clinical immunology.
[16] J. Loffing,et al. Sgk kinases and their role in epithelial transport. , 2006, Annual review of physiology.
[17] M. Dowsett,et al. Potential of endogenous estrogen receptor β to influence the selective ER modulator ERβ complex , 2005 .
[18] Jen-kun Lin,et al. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. , 2005, Carcinogenesis.
[19] Raj Kumar,et al. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. , 2005, Molecular endocrinology.
[20] Raj Kumar,et al. Gene regulation by the glucocorticoid receptor: Structure:function relationship , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[21] Andrew H. Miller,et al. Inhibition of Jun N-Terminal Kinase (JNK) Enhances Glucocorticoid Receptor-Mediated Function in Mouse Hippocampal HT22 Cells , 2005, Neuropsychopharmacology.
[22] D. Barford,et al. Molecular basis for TPR domain‐mediated regulation of protein phosphatase 5 , 2005, The EMBO journal.
[23] Qing Lu,et al. Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[24] G. Greene,et al. Plasma membrane estrogen receptors exist and functions as dimers. , 2004, Molecular endocrinology.
[25] N. Dean,et al. Constitutive over expression of serine/threonine protein phosphatase 5 (PP5) augments estrogen-dependent tumor growth in mice. , 2004, Cancer letters.
[26] L. Ou,et al. Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway. , 2004, The Journal of allergy and clinical immunology.
[27] Ye Zhang,et al. Repression of hsp90β Gene by p53 in UV Irradiation-induced Apoptosis of Jurkat Cells* , 2004, Journal of Biological Chemistry.
[28] E. Ciszak,et al. Structural Basis for the Catalytic Activity of Human Serine/Threonine Protein Phosphatase-5* , 2004, Journal of Biological Chemistry.
[29] M. Garabedian,et al. Modulation of Glucocorticoid Receptor Function via Phosphorylation , 2004, Annals of the New York Academy of Sciences.
[30] K. Horie-Inoue,et al. Protein phosphatase 5 is a negative regulator of estrogen receptor-mediated transcription. , 2004, Molecular endocrinology.
[31] A. Miller,et al. Interleukin 1α (IL-1α) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function , 2004, Molecular Psychiatry.
[32] M. Garabedian,et al. Modulation of Glucocorticoid Receptor Transcriptional Activation, Phosphorylation, and Growth Inhibition by p27Kip1* , 2003, Journal of Biological Chemistry.
[33] Heike Brand,et al. Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target Promoter , 2003, Cell.
[34] H. Kinyamu,et al. Estrogen Receptor-Dependent Proteasomal Degradation of the Glucocorticoid Receptor Is Coupled to an Increase in Mdm2 Protein Expression , 2003, Molecular and Cellular Biology.
[35] N. Dean,et al. Identification of a Functional Link for the p53 Tumor Suppressor Protein in Dexamethasone-induced Growth Suppression* , 2003, The Journal of Biological Chemistry.
[36] Jiahuai Han,et al. Inhibition of p38 MAPK by Glucocorticoids via Induction of MAPK Phosphatase-1 Enhances Nontypeable Haemophilus influenzae-induced Expression of Toll-like Receptor 2* , 2002, The Journal of Biological Chemistry.
[37] J. Saklatvala,et al. Dexamethasone Causes Sustained Expression of Mitogen-Activated Protein Kinase (MAPK) Phosphatase 1 and Phosphatase-Mediated Inhibition of MAPK p38 , 2002, Molecular and Cellular Biology.
[38] J. R. Campbell,et al. Glucocorticoids stimulate human sgk1 gene expression by activation of a GRE in its 5'-flanking region. , 2002, American journal of physiology. Endocrinology and metabolism.
[39] O. Kassel,et al. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP‐1 , 2001, The EMBO journal.
[40] C. Kirschbaum,et al. Sex Differences in Glucocorticoid Sensitivity of Proinflammatory Cytokine Production After Psychosocial Stress , 2001, Psychosomatic medicine.
[41] E. Levin. highlighted topics Genome and Hormones: Gender Differences in Physiology Invited Review: Cell localization, physiology, and nongenomic actions of estrogen receptors , 2001 .
[42] N. Dean,et al. Identification of an Estrogen-inducible Phosphatase (PP5) That Converts MCF-7 Human Breast Carcinoma Cells into an Estrogen-independent Phenotype when Expressed Constitutively* , 2001, The Journal of Biological Chemistry.
[43] Suzanne D. Conzen,et al. Glucocorticoid Receptor-mediated Protection from Apoptosis Is Associated with Induction of the Serine/Threonine Survival Kinase Gene, sgk-1 * , 2001, The Journal of Biological Chemistry.
[44] B. Darimont,et al. Novel glucocorticoid receptor coactivator effector mechanisms , 2001, Trends in Endocrinology & Metabolism.
[45] D. Feldman,et al. Estradiol inhibits glucocorticoid receptor expression and induces glucocorticoid resistance in MCF-7 human breast cancer cells , 2001, The Journal of Steroid Biochemistry and Molecular Biology.
[46] M. Ross,et al. Prevalence of asthma and other allergic diseases in an adolescent population: association with gender and race. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[47] E. Levin,et al. Estrogen Signals to the Preservation of Endothelial Cell Form and Function* , 2000, The Journal of Biological Chemistry.
[48] D. Agard,et al. Oestrogen receptor function at classical and alternative response elements. , 2000, Novartis Foundation symposium.
[49] J F Barrett,et al. Identification of CDK4 as a target of c-MYC. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[50] N. Dean,et al. Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. , 1999, Biochemistry.
[51] R. Sutherland,et al. c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry , 1998, Molecular and Cellular Biology.
[52] P. Barnes,et al. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. , 1998, Clinical science.
[53] S. Logan,et al. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[54] Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor , 1997, Molecular and cellular biology.
[55] M. Galigniana,et al. Protein Phosphatase 5 Is a Major Component of Glucocorticoid Receptor·hsp90 Complexes with Properties of an FK506-binding Immunophilin* , 1997, The Journal of Biological Chemistry.
[56] A. Silverstein,et al. The Tetratricopeptide Repeat Domain of Protein Phosphatase 5 Mediates Binding to Glucocorticoid Receptor Heterocomplexes and Acts as a Dominant Negative Mutant* , 1996, The Journal of Biological Chemistry.
[57] L. Altucci,et al. 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. , 1996, Oncogene.
[58] Miguel Beato,et al. Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.
[59] M. Gorospe,et al. Role of Mitogen-activated Protein Kinase Phosphatase during the Cellular Response to Genotoxic Stress , 1995, The Journal of Biological Chemistry.
[60] Hong Sun,et al. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo , 1993, Cell.
[61] Lin Chen,et al. Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of ERP on cell growth , 1993, Molecular and cellular biology.
[62] G. Firestone,et al. Immediate-early transcriptional regulation and rapid mRNA turnover of a putative serine/threonine protein kinase. , 1993, The Journal of biological chemistry.
[63] M. Zelen,et al. A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes. , 1985, Cancer research.
[64] W. McGuire,et al. Steroid hormone receptors in breast cancer treatment strategy. , 1980, Recent progress in hormone research.